MentalHeal Ltd.

Technology 📍 Tel Aviv, Israel 👥 51-200 employees 📅 Founded 2013

MentalHeal is developing a novel oral antipsychotic drug, PGW-5, for the treatment of schizophrenia and bipolar disorder. PGW-5 is a multi-target agent that is potentially effective for the treatment of the positive and negative symptoms of schizophrenia as well as for cognitive deficits and mood disorders.

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Technology

Country

Israel

Employees

51-200

Founded

2013

Cloud

Unknown

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	🔒 Subscribers only
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$900K – $2M / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	WordPress
Frontend Stack	🔒 Subscribers only

Detected from MentalHeal Ltd.'s public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Technology), similar size

201-500 ☁️ Unknown

Project Prometheus

51-200 ☁️ Vercel

GrubMarket Inc.

51-200 ☁️ Unknown

Data detected 2026-06-13 · Methodology · Suggest a correction